- Investing Ideas
- /
- Top Rated Asian Stocks
Top Rated Asian Stocks
UPDATED Apr 24, 2024
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
198 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NVD | US$768.00 | -4.4% | 215.6% | US$2.0t | US$959.67 | PE65.9x | E22.9% | 0.02% | Semiconductors | ||
NVDG | US$52.50 | -6.3% | 208.8% | US$2.0t | US$65.60 | PE65.9x | E22.9% | 0.02% | Semiconductors | ||
NVD | US$745.30 | -6.5% | 202.5% | US$2.0t | US$931.30 | PE65.9x | E22.9% | 0.02% | Semiconductors | ||
NFC | US$519.40 | -9.2% | 75.5% | US$239.2b | US$598.25 | PE37.2x | E16.3% | n/a | Media | ||
NFC | US$520.50 | -10.0% | 77.1% | US$239.2b | US$599.52 | PE37.2x | E16.3% | n/a | Media | ||
NFC1 | US$15.10 | -8.5% | 76.6% | US$239.2b | US$17.39 | PE37.2x | E16.3% | n/a | Media | ||
ITU | US$592.20 | 3.1% | 53.0% | US$177.9b | US$646.38 | PE64.2x | E17.4% | 0.6% | Software | ||
ITU | US$582.10 | 1.2% | 52.0% | US$177.9b | US$635.36 | PE64.2x | E17.4% | 0.6% | Software | ||
9PDA | US$118.50 | 11.3% | 102.2% | US$169.5b | US$166.92 | PE20.5x | E23.0% | n/a | Retail | ||
C9F | US$2,745.00 | 0.2% | 52.2% | US$80.4b | US$2,969.63 | PE62x | E15.9% | n/a | Consumer Services | ||
CDS | US$259.45 | -2.1% | 41.6% | US$75.7b | US$301.72 | PE72.3x | E17.0% | n/a | Software | ||
C9F | US$2,029.00 | 0% | 38.5% | US$70.8b | US$2,148.07 | PE57.6x | E15.9% | n/a | Consumer Services | ||
MLB1 | US$1,288.00 | -0.5% | 15.2% | US$69.5b | US$1,798.08 | PE70.4x | E26.6% | 0% | Retail | ||
MLB1 | US$1,295.40 | -1.3% | 15.4% | US$69.5b | US$1,808.41 | PE70.4x | E26.6% | 0% | Retail | ||
LTO | ₹39.80 | 2.6% | 56.7% | ₹5.0t | ₹43.18 | PE39.7x | E23.2% | 0.7% | Capital Goods | ||
D4S | JP¥28.40 | 4.6% | -12.2% | JP¥9.1t | JP¥33.49 | PE49.1x | E22.0% | 1.3% | Pharmaceuticals & Biotech | ||
DC4 | US$125.82 | 0.1% | 10.4% | US$54.6b | US$136.24 | PE100.8x | E20.2% | n/a | Healthcare | ||
DC4 | US$128.70 | 1.4% | 15.0% | US$54.6b | US$139.36 | PE100.8x | E20.2% | n/a | Healthcare | ||
1N8 | €1,418.60 | -1.4% | -2.2% | €44.0b | €1,656.27 | PE63x | E19.8% | n/a | Diversified Financials | ||
1N8U | €14.00 | 0% | -0.7% | €44.0b | €16.35 | PE63x | E19.8% | n/a | Diversified Financials | ||
1N8 | €1,428.00 | -0.7% | 1.0% | €44.0b | €1,667.24 | PE63x | E19.8% | n/a | Diversified Financials | ||
TT8 | US$78.29 | 3.5% | 34.6% | US$41.0b | US$88.52 | PE228.9x | E30.9% | n/a | Media | ||
TT8 | US$78.06 | 2.2% | 33.8% | US$41.0b | US$88.26 | PE228.9x | E30.9% | n/a | Media | ||
49V | US$83.76 | 4.7% | 586.6% | US$31.6b | US$93.00 | PE78.3x | E29.8% | 0.1% | Capital Goods |